Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Forestieri G, Terzi di Bergamo L, Deodato M, Frustaci AM, Moia R, Deambrogi C, Rasi S, Autore F, Merli M, Mattarucchi R, Fahrni G, Scarfo' L, Gussetti D, Bulian P, Zanatta A, Spina V, Bruscaggin A, Pini K, Piffaretti D, Pirosa MC, Salehi M, Marques de Almeida J, Passweg J, Cavalli F, Zucca E, Gerber B, Stussi G, Gattei V, Ghia P, Gregor M, Passamonti F, Laurenti L, Gaidano G, Tedeschi A, Rossi D, Condoluci A. Forestieri G, et al. Among authors: passamonti f. Hematol Oncol. 2022 Dec;40(5):1100-1104. doi: 10.1002/hon.3032. Epub 2022 Jun 1. Hematol Oncol. 2022. PMID: 35613703 No abstract available.
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. Kralovics R, et al. Among authors: passamonti f. N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113. N Engl J Med. 2005. PMID: 15858187 Free article.
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.
Paulli M, Arcaini L, Lucioni M, Boveri E, Capello D, Passamonti F, Merli M, Rattotti S, Rossi D, Riboni R, Berti E, Magrini U, Bruno R, Gaidano G, Lazzarino M. Paulli M, et al. Among authors: passamonti f. Ann Oncol. 2010 Jun;21(6):1189-1195. doi: 10.1093/annonc/mdp454. Epub 2009 Oct 25. Ann Oncol. 2010. PMID: 19858084 Free article.
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.
Zibellini S, Capello D, Forconi F, Marcatili P, Rossi D, Rattotti S, Franceschetti S, Sozzi E, Cencini E, Marasca R, Baldini L, Tucci A, Bertoni F, Passamonti F, Orlandi E, Varettoni M, Merli M, Rizzi S, Gattei V, Tramontano A, Paulli M, Gaidano G, Arcaini L. Zibellini S, et al. Among authors: passamonti f. Haematologica. 2010 Oct;95(10):1792-6. doi: 10.3324/haematol.2010.025437. Epub 2010 May 29. Haematologica. 2010. PMID: 20511668 Free PMC article.
Clinical predictors of outcome in MPN.
Passamonti F, Maffioli M, Merli M, Ferrario A, Caramazza D. Passamonti F, et al. Hematol Oncol Clin North Am. 2012 Oct;26(5):1101-16. doi: 10.1016/j.hoc.2012.07.009. Epub 2012 Aug 28. Hematol Oncol Clin North Am. 2012. PMID: 23009940 Review.
Novel agents in indolent lymphomas.
Merli M, Ferrario A, Basilico C, Maffioli M, Caramazza D, Appio L, Arcaini L, Passamonti F. Merli M, et al. Among authors: passamonti f. Ther Adv Hematol. 2013 Apr;4(2):133-48. doi: 10.1177/2040620712466865. Ther Adv Hematol. 2013. PMID: 23610620 Free PMC article.
Everolimus in diffuse large B-cell lymphomas.
Merli M, Ferrario A, Maffioli M, Arcaini L, Passamonti F. Merli M, et al. Among authors: passamonti f. Future Oncol. 2015;11(3):373-83. doi: 10.2217/fon.14.264. Future Oncol. 2015. PMID: 25675120 Review.
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.
Ferrario A, Merli M, Basilico C, Maffioli M, Passamonti F. Ferrario A, et al. Among authors: passamonti f. Expert Opin Investig Drugs. 2017 Mar;26(3):367-373. doi: 10.1080/13543784.2017.1288213. Epub 2017 Feb 9. Expert Opin Investig Drugs. 2017. PMID: 28140696 Review.
433 results